# GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer

> **NCT01487720** · PHASE2 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 33 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** GEMOX

## Key facts

- **NCT ID:** NCT01487720
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2013-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01487720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01487720, "GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01487720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*